301 related articles for article (PubMed ID: 11600380)
1. High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan.
Hsueh PR; Teng LJ; Lee LN; Ho SW; Yang PC; Luh KT
Antimicrob Agents Chemother; 2001 Nov; 45(11):3205-8. PubMed ID: 11600380
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany.
Schoening TE; Wagner J; Arvand M
Clin Microbiol Infect; 2005 Jul; 11(7):579-82. PubMed ID: 15966978
[TBL] [Abstract][Full Text] [Related]
3. A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand.
Malbruny B; Werno AM; Anderson TP; Murdoch DR; Leclercq R
J Antimicrob Chemother; 2004 Dec; 54(6):1040-4. PubMed ID: 15537693
[TBL] [Abstract][Full Text] [Related]
4. Polyclonal spread of erythromycin-resistant Streptococcus agalactiae in southern Taiwan.
Ko WC; Yan JJ; Lee NY; Wu HM; Wu JJ
Microb Drug Resist; 2004; 10(4):306-12. PubMed ID: 15650375
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization and antimicrobial susceptibility profiles in Streptococcus agalactiae colonizing strains: association of erythromycin resistance with subtype III-1 genetic clone family.
Florindo C; Viegas S; Paulino A; Rodrigues E; Gomes JP; Borrego MJ
Clin Microbiol Infect; 2010 Sep; 16(9):1458-63. PubMed ID: 19886900
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of erythromycin resistance in group B streptococcal isolates at a University Hospital in Taiwan.
Janapatla RP; Ho YR; Yan JJ; Wu HM; Wu JJ
Microb Drug Resist; 2008 Dec; 14(4):293-7. PubMed ID: 19025386
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and mechanisms of erythromycin resistance in Streptococcus agalactiae from healthy pregnant women.
Pinheiro S; Radhouani H; Coelho C; Gonçalves A; Carvalho E; Carvalho JA; Ruiz-Larrea F; Torres C; Igrejas G; Poeta P
Microb Drug Resist; 2009 Jun; 15(2):121-4. PubMed ID: 19432524
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada.
de Azavedo JC; McGavin M; Duncan C; Low DE; McGeer A
Antimicrob Agents Chemother; 2001 Dec; 45(12):3504-8. PubMed ID: 11709331
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile.
Palavecino EL; Riedel I; Berrios X; Bajaksouzian S; Johnson D; Kaplan E; Jacobs MR
Antimicrob Agents Chemother; 2001 Jan; 45(1):339-41. PubMed ID: 11120993
[TBL] [Abstract][Full Text] [Related]
10. Anti-microbial susceptibility of Streptococcus spp. isolated from bovine mastitis in Argentina.
Denamiel G; Llorente P; Carabella M; Rebuelto M; Gentilini E
J Vet Med B Infect Dis Vet Public Health; 2005 Apr; 52(3):125-8. PubMed ID: 15876224
[TBL] [Abstract][Full Text] [Related]
11. Inducible clindamycin resistance in β-hemolytic streptococci and Streptococcus pneumoniae.
Megged O; Assous M; Weinberg G; Schlesinger Y
Isr Med Assoc J; 2013 Jan; 15(1):27-30. PubMed ID: 23484235
[TBL] [Abstract][Full Text] [Related]
12. [Macrolide resistance phenotypes and genotypes in group G streptococci].
Açikgöz ZC; Göçer S; Almayanlar E
Mikrobiyol Bul; 2003; 37(2-3):117-24. PubMed ID: 14593892
[TBL] [Abstract][Full Text] [Related]
13. [Phenotypes and mechanisms of resistance to macrolides and lincosamides in Streptococcus agalactiae isolates with clinical significance in an eight-year period (2002-2010)].
Campelo FA; Pedrosa AC; Antúnez IÁ; Capuz BL
Rev Esp Quimioter; 2012 Mar; 25(1):42-6. PubMed ID: 22488541
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.
Uh Y; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
Antimicrob Agents Chemother; 2004 Jul; 48(7):2716-8. PubMed ID: 15215133
[TBL] [Abstract][Full Text] [Related]
15. [Streptococcus agalactiae increase in resistance to erythromycin and clindamycin in vaginal-anal colonization in third quarter of pregnancy in one decade of universal screening].
Abarzúa F; Arias A; García P; Ralph C; Cerda J; Riedel I; Gárate C
Rev Chilena Infectol; 2011 Aug; 28(4):334-7. PubMed ID: 22052397
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea.
Uh Y; Shin DH; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
J Antimicrob Chemother; 2004 Jun; 53(6):1095-7. PubMed ID: 15117924
[TBL] [Abstract][Full Text] [Related]
17. Streptococcus agalactiae in a large Portuguese teaching hospital: antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates.
Figueira-Coelho J; Ramirez M; Salgado MJ; Melo-Cristino J
Microb Drug Resist; 2004; 10(1):31-6. PubMed ID: 15140391
[TBL] [Abstract][Full Text] [Related]
18. Analysis of phenotype, genotype and serotype distribution in erythromycin-resistant group B streptococci isolated from vaginal flora in Southern Ireland.
Kiely RA; Lucey B; Cotter L
Epidemiol Infect; 2010 Feb; 138(2):286-91. PubMed ID: 19602300
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and mechanisms of erythromycin and clindamycin resistance in clinical isolates of beta-haemolytic streptococci of Lancefield groups A, B, C and G in Seville, Spain.
Merino Díaz L; Torres Sánchez MJ; Aznar Martín J
Clin Microbiol Infect; 2008 Jan; 14(1):85-7. PubMed ID: 18034859
[TBL] [Abstract][Full Text] [Related]
20. [Serotypes and antimicrobial susceptibility of Streptococcus agalactiae].
Martínez MA; Ovalle A; Durán C; Reid I; Urriola G; Garay B; Cifuentes M
Rev Med Chil; 2004 May; 132(5):549-55. PubMed ID: 15279140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
